Want to join the conversation?
$ADMS said the phase 3 EASE LID trial results showed a 23% reduction in levodopa-induced dyskinesia (LID) for ADS-5102-treated patients compared to placebo. The reduction in LID was maintained at 24 weeks, a key secondary analysis. $ADMS plans to present comprehensive data at an upcoming scientific conference.
$AAL is giving pay hikes to its employees but investors are sulking.
$APC stock tumbled more than 5.6% after last week's fatal home explosion in Firestone, Colorado prompted the company to close more than 3,000 wells for weeks.
Unicorn Frappuccino. The latest hit from $SBUX. Can't wait to see how this will affect its results.
At what point should $AMZN consider a stock split? $1000 per share seems pretty high.